General form of registration statement for all companies including face-amount certificate companies

Stockholders' Equity (Tables)

v3.20.4
Stockholders' Equity (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Equity [Abstract]    
Schedule of Outstanding Warrants

At September 30, 2020, outstanding warrants to purchase shares of common stock accounted for as equity or liabilities were as follows with an aggregate intrinsic value as of September 30, 2020 of zero:

 

Shares Underlying              
Outstanding     Exercise     Expiration  
Warrants     Price(1)     Date(1)  
               
  100,870     $ 7.1875       September 24, 2025  
  100,870                  

 

(1) The warrants are exercisable at any time and from time to time, in whole or in part, during a period commencing March 24, 2021 and expiring September 24, 2025. The exercise price of the warrants is $7.1875 per share or $6.9718 per share if the warrants are exercised for cash within the first six months of the period in which they are exercisable.

No new warrants were granted in 2019 and 2018. At December 31, 2018, outstanding warrants to purchase shares of common stock, accounted for as equity or liabilities, are as follows:

 

Shares Underlying Outstanding Warrants     Exercise Price     Expiration Date
  302,256     $ 0.27     July 27, 2020
  155,433     $ 1.34     September 20, 2020
  159,085     $ 2.67     September 30, 2020
  592,700     $ 5.34     June 30, 2021
  604,703     $ 5.34     June 30, 2022
  262,173     $ 5.34     June 30, 2023
  280,899     $ 5.34     June 30, 2024
  318,353     $ 5.34     June 30, 2025
  2,675,602              

 

As of December 31, 2019 there are no outstanding warrants to purchase shares of common stock, accounted for as equity or liabilities.

 

Shares Underlying Outstanding Warrants as of December 31, 2018     Shares Underlying Warrants Exchanged on September 30, 2019     Shares Underlying Outstanding Warrants as of December 31, 2019  
  2,675,602       (2,675,602)